Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Standard Chartered, IG Group

(Sharecast News) - Citi reiterated its 'neutral' rating on Standard Chartered on Wednesday after the company's investor update a day earlier. In an update on Tuesday, StanChart announced plans to cut nearly 8,000 jobs and set higher medium-term profitability targets.

"We welcomed the investor update which clearly outlined the differentiating factors in the StanChart business model and where incremental investment is envisaged to position the bank for the future and drive structural top-line growth," Citi said.

"Trading on 1.1x P/TB for a more than 15% target return on tangible equity in 2028 and 5-7% target revenue compound annual growth rate, the stock appears inexpensive."

That said, Citi expects the initial debates will focus on the 2027-28 cost trajectory and capital allocation priorities, with the targets implying a step-up in cost growth and potentially lower buybacks than consensus assumes. This may limit consensus earnings per share upgrades and hold the shares back near-term, it said.

Deutsche Bank lifted its price target on IG Group on Wednesday to 1,750p from 1,650p after the online trading provider upgraded its guidance for 2026 and its medium-term outlook as it reported a jump in first-quarter revenue.

Deutsche said Q1 total revenue was around 13% ahead of recently-issued guidance and 6% ahead of its own forecast, driven by higher volatility in the period, in particular in the core OTC segment, more than offsetting slightly weaker outcomes in the other areas.

"Management guidance is also increased, with FY26 organic revenue now expected to grow 10-15% (versus high single digits % previously) and future years more than 10% (vs high single digits % previously)," it noted.

"EBITDA margin guidance in the mid-40s% is unchanged, we think reflecting the higher revenue being generated being reinvested into further customer acquisition/marketing costs, which in turn should help to drive future revenue growth from a higher installed customer base."

Overall, DB said the new guidance implies low-mid single digit percentage increases in revenue and EBITDA versus previous guidance. "We view this as a robust update," it said.

Share this article

Related Sharecast Articles

Broker tips: Anglo American, On The Beach
(Sharecast News) - Jefferies reiterated its 'buy' rating on Anglo American on Tuesday after the miner announced an agreement to sell its portfolio of steelmaking coal mines in Australia to private UK mining company Dhilmar for up to $3.9bn in cash.
Broker tips: AstraZeneca, GSK, Oxford Instruments
(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-quarter earnings season.
Broker tips: Aegon, Standard Life, Aberdeen, Card Factory
(Sharecast News) - JPMorgan reiterated its 'overweight' stance on Aegon on Friday and double-upgraded Standard Life as it said the sale of Aegon UK to Standard Life is highly likely to receive regulatory approval, which would be "very positive for both".

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.